Bernhard Hering, MD

Executive Director, Schulze Diabetes Institute

Bernhard Hering

Contact Info

Office Phone 612-626-5697

Office Address:
Schulze Diabetes Institute
420 Delaware Street SE
Mayo Mail Code 195
Minneapolis, MN 55455

Administrative Assistant Name
Kelly Swenson

Administrative Phone

Administrative Email

Executive Director, Schulze Diabetes Institute

Professor, Department of Surgery

Research Chair, Islet Cell Transplantation Program Eunice L. Dwan Diabetes

M.D., Justus-Liebig-University, Giessen, Germany, 1983

Residency, Justus-Liebig-University, Giessen, Germany, 1985-1995 (Internal Medicine)

Fellowship, Justus-Lieb-University, Giessen, Germany, 1995-1996 (Endocrinology)


Dr. Hering is internationally renowned for his expertise in islet cell transplantation. His research focuses on finding innovative cell-based therapies to restore blood glucose control and insulin independence for people with type 1 diabetes. Additionally, he is committed to exploring new sources of islet cells through xenotransplantation.

He is the medical director of the Collaborative Islet Transplant Registry (CITR), and has also served as president of the Cell Transplant Society and as councilor of the International Pancreas and Islet Transplant Association.

Dr. Hering also serves on steering committees of major clinical research programs in transplantation and diabetes such as the National Institutes of Health (NIH) Immune Tolerance Network, the Type 1 Diabetes TrialNet, and the Clinical Islet Transplant Consortium, which is the largest ever funded research activity in islet transplantation


  • Diabetes
  • Islet transplantat
  • Pancreatectomy and auto islet transplant
  • solid organ transplant

Professional Associations

Past-President of the International Pancreas and Islet Transplant Association
Past-President of the International Xenotransplantation Association


Research Summary/Interests

Cell Biology and Immunobiology of Islet Transplantation in Preclinical Models


Clinical Interests

Islet Transplantation for Treatment of Type I Diabetes